Authors


DANA BYRNE, MD, MSCE

Latest:

Hospital-Acquired and Ventilator-Associated Pneumonia: Highlights and Pitfalls of the 2016 IDSA / ATS Guidelines

Hospital-acquired and ventilator-associated pneumonia account for 22% of all hospital-acquired infections.


CONAN MACDOUGALL, PHARMD

Latest:

Multidrug-Resistant Pseudomonas aeruginosa Infections: Hard to Treat, But Hope on the Horizon?

Two recently approved agents offer significant activity against these hard-to-treat conditions.


Jessica Burchette, PharmD, BCPS

Latest:

Guidelines to Caring for Patients With Sepsis: Promise or Progress?

Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.


Khalid Eljaaly, PharmD, MS, BCPS, BCIDP*

Latest:

Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumonia

This article highlights some key updates to the antimicrobial therapy recommendations in the updated community-acquired pneumonia guidelines.


Susan Kreimer, MS

Latest:

Hepatitis C and the Dwindling of Research Funding

Hepatitis C virus is the world’s most prevalent blood-borne viral infection for which a vaccine does not exist. To eliminate HCV infection on a global scale, experts argue that vaccine development needs to become a public health priority.


J. Drew Zimmer, PharmD, BCPS *

Latest:

Is Eravacycline Ready for Prime Time Against CRAB Pneumonia?

Eravacycline is an antibiotic that has been touted for possible treatment of difficult-to-treat resistant (DTR) Gram-negative infections. But can it tackle carbapenem-resistant Acinetobacter baumannii (CRAB) infections?




BEJOY PAUL MANIARA, PHARMD, BCPS, BCIDP

Latest:

The Search Continues for How to Best Treat Non—Carbapenemase-Producing CRE Infections

Infections caused by non–carbapenemase-producing carbapenem-resistant Enterobacteriaceae present challenges in the treatment paradigm. Given the limited clinical data, the preferred therapeutic approach remains unknown.


DONG HEUN LEE, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.



William Todd Penberthy, PhD

Latest:

Examining the Surprisingly High Impact of Viruses on CAP and the Utility of Procalcitonin in Treatment Decisions

The impact of viruses on community-acquired pneumonia seems to be greater than initially realized and the use of procalcitonin may help distinguish infection type for appropriate treatment.


SAFIA KURIAKOSE, PHARMD, BCPS-AQ ID

Latest:

Ibalizumab Effective for Multidrug-Resistant HIV-1 Infection

This orphan drug is for patients with limited antiretroviral treatment options.


Adam Hochron

Latest:

New Study Provides Hope for Chronic Lyme Disease Sufferers

Patients with Lyme disease know that their symptoms and the effects of the disease can be debilitating and last for a long time, often persisting even after treatment.


Carolyn Colwell

Latest:

UNC Study Finds Some HIV Patients with Low Viral Loads Forgo Treatment

A recent UNC study found that about one-third of HIV-positive patients with low viral loads chose to ignore federal guidelines to begin ART.


ELIZABETH HIRSCH, PHARMD, RPH

Latest:

What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?

In addition to other updates, new breakpoints have been added for cefiderocol and meropenem-vaborbactam.


Tiffany Lee, PharmD, BCIDP

Latest:

Double Trouble: Assessing the Impact of Combining Daptomycin and Fosfomycin for MRSA Bacteremia

This highlighted study looks at using these 2 therapies concurrently for this infection.


Silas Inman

Latest:

SARS-CoV-2 Vaccine Shows Signs of Activity in Phase 1/2 Study

BNT162b1, a SARS-CoV-2 vaccine candidate, elicited promising early signs of immune activity in a placebo-controlled phase 1/2 study.


DEVANG PATEL, MD

Latest:

New Initiatives for HIV Taking Off This Year

Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.


Joanna Lorenz

Latest:

Cognitive Disorders are a Risk Factor for Severe COVID-19

Alzheimer’s disease, dementia, and genetic variations in areas key to viral infection are risk factors for severe COVID-19 a new study suggests.


ANNE BORJA, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Payal K. Patel MD, MPH

Latest:

It Takes Two to TANGO With a Carbapenemase

Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.


Aislinn Antrim

Latest:

Texas Could Be Site of Next Large Measles Outbreak, Study Predicts

Texas could be the site of the next large measles outbreak in the United States, according to a new study that highlights the low vaccination rates among schools there.


SEAN BULLIS, MD

Latest:

Improving Vaccine Uptake in a Cohort of Patients With Asplenia

This is one of the first studies examining the effect of a dedicated postsplenectomy comprehensive clinic.


HELEN W. BOUCHER, MD

Latest:

Implications of the 21st Century Cures Act on Antibiotic Drug Development

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.


Carly Sedlock, MD

Latest:

COVID-19: How Temple University Hospital Is Addressing the Pandemic

The health system’s response could be used as a teaching model for addressing future infectious disease threats.


Sujit Suchindran, MD

Latest:

The Infectious Disease Physician's Holiday Wish List

For all you last-minute shoppers, Payal K. Patel MD, MPH, and Sujit Suchindran MD, have put together a wish list of the top items to get the infectious disease physician in your life.


Kelsey Fontneau, PharmD Candidate

Latest:

Women Living With HIV and Menopause: Bridging the Data Gap

Women living with HIV are at elevated risk for comorbidities as their life expectancy increases.


Bradley Langford, PharmD, BCPS*

Latest:

"Antibiotic Never Events": The Ideal Target to Reduce Antimicrobial Exposure

By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.


Alia Al-Tayyib, PhD, MSPH

Latest:

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.

© 2025 MJH Life Sciences

All rights reserved.